ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

PLSH Panacea Life Sciences Holdings Inc (PK)

0.061
0.00 (0.00%)
Last Updated: 13:01:47
Delayed by 15 minutes
Share Name Share Symbol Market Type
Panacea Life Sciences Holdings Inc (PK) USOTC:PLSH OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.061 0.0611 0.10 0.00 13:01:47

Statement of Changes in Beneficial Ownership (4)

05/08/2022 4:17pm

Edgar (US Regulatory)


FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Buttorff Leslie
2. Issuer Name and Ticker or Trading Symbol

PANACEA LIFE SCIENCES HOLDINGS, INC. [ PLSH ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                    __X__ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
CEO
(Last)          (First)          (Middle)

5910 SOUTH UNIVERSITY BLVD, C18-193
3. Date of Earliest Transaction (MM/DD/YYYY)

8/3/2022
(Street)

GREENWOOD VILLAGE, CO 80121
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 8/3/2022  P  1000 A$0.0955 628149 D  
Common Stock 8/4/2022  P  5100 A$0.10 633249 D  
Common Stock 8/4/2022  P  1000 A$0.10 634249 D  
Common Stock 8/4/2022  P  2500 A$0.093 636749 D  
Common Stock 8/4/2022  P  2600 A$0.10 639349 D  
Common Stock 8/4/2022  P  5000 A$0.10 644349 D  
Common Stock 8/4/2022  P  100 A$0.11 644449 D  
Common Stock 8/4/2022  P  500 A$0.098 644949 D  
Common Stock 8/4/2022  P  1000 A$0.093 645949 D  
Common Stock         4047054 I Held by Quintel-MC, Incorporated 
Series C Preferred Stock         1000000 I Held by Quintel-MC, Incorporated 
Series C-1 Preferred Stock         10000 I Held by Quintel-MC, Incorporated 
Series C-2 Preferred Stock         100 I Held by Quintel-MC, Incorporated 
Series D Preferred Stock         10000 I Held by J&N Real Estate Company LLC 

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares

Explanation of Responses:

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Buttorff Leslie
5910 SOUTH UNIVERSITY BLVD, C18-193
GREENWOOD VILLAGE, CO 80121
XXCEO

Signatures
/s/ Leslie Buttorff8/5/2022
**Signature of Reporting PersonDate


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

1 Year Panacea Life Sciences (PK) Chart

1 Year Panacea Life Sciences (PK) Chart

1 Month Panacea Life Sciences (PK) Chart

1 Month Panacea Life Sciences (PK) Chart